Nasal Allergies (Rhinitis)



Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis (SAR)
Interventions:   Drug: GSP 301 NS;   Drug: GSP 301 Placebo NS
Sponsor:   Glenmark Specialty S.A.
Recruiting


Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: Molo 1 (also referred as GSP 301-2 NS);   Drug: Molo 2 (also referred as GSP 301-1 NS);   Drug: Placebo nasal spray;   Drug: DYMISTA nasal spray;   Drug: PATANASE nasal spray
Sponsor:   Glenmark Pharmaceuticals Ltd. India
Completed


Role of Montelukast in Asthma and Allergic Rhinitis Patients


Condition:   Asthma and Allergic Rhinitis
Intervention:   Drug: Montelukast 10mg
Sponsor:   Clinision
Not yet recruiting


Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Drug: Benjakul Extract;   Drug: Loratadine
Sponsor:   Thammasat University
Recruiting


A Novel Biologic Therapy for Perennial Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Allergen Immunotherapy Extract;   Drug: Allergen Immunotherapy Control
Sponsor:   Johns Hopkins University
Recruiting


Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Resveratrol plus Carboxymethyl-β-Glucan;   Drug: Placebo
Sponsor:   Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting


Integrative Omics Approach to Allergic Rhinitis


Condition:   Allergic Rhinitis
Intervention:  
Sponsors:   Medical University of Graz;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting


Effect of Air Cleaner on the Indoor Allergen Sensitized Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Device: PuriCare (HEPA Air Cleaner);   Device: Mock device of PuriCare
Sponsor:   Yonsei University
Completed


Validation of an Allergic Rhinitis Control Test in Children


Condition:   Allergic Rhinitis
Intervention:   Other: Self Questionnaire
Sponsor:   University Hospital, Montpellier
Recruiting


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting


Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis (SAR)
Interventions:   Drug: GSP 301 NS;   Drug: GOM-NS;   Drug: GMM-2 NS;   Drug: GSP 301 placebo NS
Sponsor:   Glenmark Specialty S.A.
Completed


Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GSP 301 Placebo NS pH 3.7;   Drug: GSP 301 Placebo NS pH 7
Sponsor:   Glenmark Specialty S.A.
Completed


Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
Sponsors:   Gachon University Gil Medical Center;   Korea Research Foundation
Recruiting


Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Nasal Beclomethasone Dipropionate;   Drug: CERCHIO 10 mg/ml OS
Sponsor:   Stefania La Grutta, MD
Completed


Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GOM NS;   Drug: GMM-2 NS;   Drug: GSP 301 Placebo NS
Sponsor:   Glenmark Specialty S.A.
Completed


Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine


Condition:   Allergic Rhinitis
Interventions:   Drug: Bilastine;   Drug: Loratadine
Sponsor:   Universidade do Sul de Santa Catarina
Completed


Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Budesonide nasal spray (100 mcg bid);   Drug: Budesonide nasal spray (50 mcg bid
Sponsor:   Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Completed


To Study GSP 301 in Patients With Seasonal Allergic Rhinitis


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: GSP 301-1 NS (QD);   Drug: GSP 301-2 NS (BID);   Drug: GSP 301 Placebo NS;   Drug: Olopatadine HCl-1 NS (QD);   Drug: Olopatadine HCl-2 NS (BID);   Drug: Mometasone Furoate-1 NS (QD);   Drug: Mometasone Furoate-2 NS (BID)
Sponsor:   Glenmark Pharmaceuticals Ltd. India
Completed


The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis


Condition:   Other Allergic Rhinitis
Intervention:   Procedure: nasal allergen provocation test
Sponsor:   Mahidol University
Completed


The Efficacy and Safety of Sanfujiu on Patients With Persistent Allergic Rhinitis: Randomized Controlled Study


Condition:   Allergic Rhinitis
Interventions:   Drug: Sanfujiu;   Drug: Placebo
Sponsor:   Guangdong Provincial Hospital of Traditional Chinese Medicine
Active, not recruiting


Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis


Condition:   Seasonal Allergic Rhinitis
Intervention:   Device: acupressure pellets
Sponsor:   University of Mississippi Medical Center
Terminated


Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Ketorolac Tromethamine;   Drug: Oxymetazoline Hydrochloride;   Drug: Fluticasone Propionate
Sponsor:   Egalet Ltd
Completed


Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: Olopatadine hydrochloride 0.6% nasal spray (PATANASE);   Other: Olopatadine nasal spray vehicle, pH 3.7;   Other: Olopatadine nasal spray vehicle, pH 7.0
Sponsor:   Alcon Research
Completed


Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: desloratadine;   Drug: fexofenadine;   Drug: placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Refine Your Search Advanced Search